<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81718">
  <stage>Registered</stage>
  <submitdate>27/11/2006</submitdate>
  <approvaldate>5/12/2006</approvaldate>
  <actrnumber>ACTRN12606000503527</actrnumber>
  <trial_identification>
    <studytitle>The effect of propofol or propofol plus midazolam and/or fentanyl on cognitive impairment following colonoscopy</studytitle>
    <scientifictitle>The effect of propofol or propofol plus midazolam and/or fentanyl on cognitive impairment following colonoscopy</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Patients undergoing colonoscopy</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Normal oral and gastrointestinal development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>2. Sedation individually titrated for patient requirement for the duration of colonoscopy (10-60 minutes) with variable dose intravenous propofol (50-400 mg) plus variable dose intravenous midazolam (0.5-5 mg) and/or variable dose intravenous fentanyl (10-100 mcg)</interventions>
    <comparator>1. Sedation individually titrated for patient requirement for the duration of colonoscopy (10-60 minutes) with a variable dose intravenous propofol (50-400 mg)</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognitive impairment</outcome>
      <timepoint>At discharge from colonoscopy suite</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>1. Depth of sedation every 5 min during sedation</outcome>
      <timepoint>Every 5 min while patients are sedated during colonoscopy.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>2. Endoscopist satisfaction with intraoperative conditions</outcome>
      <timepoint>Measured at the end of colonoscopy</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>3. Complications</outcome>
      <timepoint>Recorded at the end of colonoscopy</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>4. Dreaming during sedation </outcome>
      <timepoint>Recorded on emergence from sedation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients who present for elective outpatient colonoscopy, not combined with other procedures and following full bowel preparation. </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with cognitive deficits and without adequate English language comprehension.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation will be concealed in opaque envelopes until after patient consent has been obtained</concealment>
    <sequence>Simple randomisation by using a randomisation table created by a computer software (ie. computerised sequence generation)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Subjects, endoscopists, post-operative observers and data analysts will be blind to group allocation.</designfeatures>
    <endpoint>Pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/02/2007</anticipatedstartdate>
    <actualstartdate>6/12/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>22/02/2008</actualenddate>
    <samplesize>200</samplesize>
    <actualsamplesize>200</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Melbourne Health Research Directorate</primarysponsorname>
    <primarysponsoraddress>Grattan St
Parkville Victoria 3050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Melbourne Hospital</fundingname>
      <fundingaddress>Grattan St Parkville VIC 3050</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Patients having colonoscopy under sedation may remain sedated for some hours afterwards. This may mean that they cannot return to work inside or outside the home. Our hypothesis is that patients who receive midazolam and fentanyl, as well as propofol, will be more sedated than those who receive propofol alone, at the time of hospital discharge.</summary>
    <trialwebsite />
    <publication>Padmanabhan U, LESLIE K, Eer A, Maruff P, Silbert BS. Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg 2009; 109:1448-55</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Melbourne Hospital</ethicname>
      <ethicaddress>Grattan St Parkville VIC 3050</ethicaddress>
      <ethicapprovaldate>1/02/2007</ethicapprovaldate>
      <hrec>2006.228</hrec>
      <ethicsubmitdate>1/11/2006</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050</address>
      <phone>+61 3 93427540</phone>
      <fax>+61 3 93428623</fax>
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050</address>
      <phone>+61 3 93427540</phone>
      <fax>+61 3 93428623</fax>
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050
Australia
</address>
      <phone>+61-3-93427540</phone>
      <fax />
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>